{"id":"https://openalex.org/W4281749036","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.11505","title":"Long-term outcomes in patients with localized Ewing sarcoma treated with interval-compressed chemotherapy: A long-term follow-up report from Children\u2019s Oncology Group study AEWS0031.","display_name":"Long-term outcomes in patients with localized Ewing sarcoma treated with interval-compressed chemotherapy: A long-term follow-up report from Children\u2019s Oncology Group study AEWS0031.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281749036","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.11505"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.11505","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.11505","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.11505","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Thomas Cash","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Cash","raw_affiliation_strings":["Aflac Cancer & Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aflac Cancer & Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA;","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090325707","display_name":"Mark Krailo","orcid":"https://orcid.org/0000-0002-7608-0698","observed_orcids":["https://orcid.org/0000-0002-7608-0698"]},"institutions":[{"id":"https://openalex.org/I4210134079","display_name":"Children's Oncology Group","ror":"https://ror.org/03yyg2352","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210134079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark D. Krailo","raw_affiliation_strings":["Children's Oncology Group, Arcadia, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group, Arcadia, CA;","institution_ids":["https://openalex.org/I4210134079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110253725","display_name":"Allen B. Buxton","orcid":"https://orcid.org/0009-0005-4376-1250","observed_orcids":["https://orcid.org/0009-0005-4376-1250"]},"institutions":[{"id":"https://openalex.org/I4210134079","display_name":"Children's Oncology Group","ror":"https://ror.org/03yyg2352","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210134079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen Buxton","raw_affiliation_strings":["Children's Oncology Group, Arcadia, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group, Arcadia, CA;","institution_ids":["https://openalex.org/I4210134079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063084227","display_name":"Bruce Pawel","orcid":"https://orcid.org/0000-0001-7678-5324","observed_orcids":["https://orcid.org/0000-0001-7678-5324"]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce Pawel","raw_affiliation_strings":["Children's Hospital Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022207361","display_name":"John H. Healey","orcid":"https://orcid.org/0000-0002-0802-1186","observed_orcids":["https://orcid.org/0000-0002-0802-1186"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John H. Healey","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058252063","display_name":"Odion T. Binitie","orcid":"https://orcid.org/0000-0002-2674-9939","observed_orcids":["https://orcid.org/0000-0002-2674-9939"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Odion Binitie","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111971396","display_name":"Karen Chayt Marcus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Chayt Marcus","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011956202","display_name":"Holcombe E. Grier","orcid":"https://orcid.org/0009-0001-7701-2304","observed_orcids":["https://orcid.org/0009-0001-7701-2304"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Holcombe E. Grier","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001066329","display_name":"Steven G. DuBois","orcid":"https://orcid.org/0000-0003-0882-738X","observed_orcids":["https://orcid.org/0000-0003-0882-738X","https://orcid.org/0000-0001-7575-2969"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven G. DuBois","raw_affiliation_strings":["Dana-Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children\u2019s Cancer and Blood Disorders Center, Boston, MA;","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028721392","display_name":"Patrick Joseph Grohar","orcid":"https://orcid.org/0000-0002-1071-4563","observed_orcids":["https://orcid.org/0000-0002-1071-4563"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Grohar","raw_affiliation_strings":["Children's Hospital of Philadelphia, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital of Philadelphia, Philadelphia, PA;","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029966550","display_name":"Damon R. Reed","orcid":"https://orcid.org/0000-0002-8238-2465","observed_orcids":["https://orcid.org/0000-0002-8238-2465"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Damon R. Reed","raw_affiliation_strings":["H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006299598","display_name":"Aaron R. Weiss","orcid":"https://orcid.org/0000-0001-8352-3963","observed_orcids":["https://orcid.org/0000-0001-8352-3963"]},"institutions":[{"id":"https://openalex.org/I4210123774","display_name":"Maine Medical Center","ror":"https://ror.org/034c1gc25","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210102705","https://openalex.org/I4210123774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron R. Weiss","raw_affiliation_strings":["Maine Medical Center, Portland, ME;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maine Medical Center, Portland, ME;","institution_ids":["https://openalex.org/I4210123774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032743242","display_name":"Richard Greg Gorlick","orcid":"https://orcid.org/0000-0001-8995-2929","observed_orcids":["https://orcid.org/0000-0001-8995-2929"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Greg Gorlick","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056053037","display_name":"Katherine A. Janeway","orcid":"https://orcid.org/0000-0001-6000-3594","observed_orcids":["https://orcid.org/0000-0001-6000-3594"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine A. Janeway","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081072468","display_name":"Richard B. Womer","orcid":"https://orcid.org/0000-0002-4405-1200","observed_orcids":["https://orcid.org/0000-0002-4405-1200"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard B. Womer","raw_affiliation_strings":["Children's Hospital of Philadelphia, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital of Philadelphia, Philadelphia, PA;","institution_ids":["https://openalex.org/I1335321130"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"11505","last_page":"11505"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11141","display_name":"Childhood Cancer Survivors' Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.8100000023841858},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9890000224113464},{"id":"https://openalex.org/keywords/secondary-malignancies","display_name":"secondary malignancies","score":0.9789999723434448},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6660000085830688},{"id":"https://openalex.org/keywords/pediatric-cancer","display_name":"childhood cancer","score":0.4740000069141388},{"id":"https://openalex.org/keywords/pelvic-tumors","display_name":"pelvic tumors","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9093310832977295},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6600561738014221},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6393946409225464},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6368001103401184},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.6040723323822021},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5540496706962585},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5437601208686829},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.5167316794395447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5115709900856018},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.5042096376419067},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4981234073638916},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4894491732120514},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.45594844222068787},{"id":"https://openalex.org/C66339696","wikidata":"https://www.wikidata.org/wiki/Q6089397","display_name":"Log-rank test","level":3,"score":0.4348001480102539},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.32511574029922485},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.16518622636795044},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09631362557411194}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.11505","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.11505","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.11505","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6700000166893005,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386316250","https://openalex.org/W2128628566","https://openalex.org/W2970450487","https://openalex.org/W3205415979","https://openalex.org/W4379341621","https://openalex.org/W4416543358","https://openalex.org/W4410803389","https://openalex.org/W4229444397","https://openalex.org/W4225571434","https://openalex.org/W4406795102"],"abstract_inverted_index":{"11505":[0],"Background:":[1],"Children\u2019s":[2],"Oncology":[3],"Group":[4],"study":[5,440],"AEWS0031":[6,45,61],"demonstrated":[7,365],"superior":[8,279,430],"5-year":[9],"event-free":[10],"survival":[11,50,153],"(EFS)":[12],"in":[13,134,250,286,402,437],"patients":[14,42,65,133,179,281,313,352,367,390,407,442],"with":[15,66,181,200,256,283,314,332,341,353,368,408,429,446],"localized":[16,67,425],"Ewing":[17],"sarcoma":[18],"(ES)":[19],"receiving":[20,252],"interval-compressed":[21],"(IC)":[22],"chemotherapy":[23,32,54,423],"(every":[24,33],"2":[25,109],"weeks)":[26],"compared":[27,162,186,203,229],"to":[28,46,91,123,187,204,230,469],"standard":[29],"timing":[30],"(ST)":[31],"3":[34,102],"weeks).":[35],"We":[36],"assessed":[37],"the":[38,49,158,164,196,275,288,311,319,323,388,403,463],"long-term":[39],"outcome":[40],"of":[41,52,95,125,131,215,325,382],"treated":[43,180,282],"on":[44],"determine":[47],"whether":[48],"advantage":[51],"IC":[53,182,201,237,253,284,372,422,460],"was":[55,120,184,198,223,243,278,328,399],"maintained":[56],"at":[57,454],"10":[58],"years.":[59],"Methods:":[60],"enrolled":[62],"568":[63],"eligible":[64],"ES.":[68],"Patients":[69],"were":[70,144,155,396],"stratified":[71],"into":[72],"four":[73],"groups":[74],"by":[75,362],"age":[76,308],"(<18":[77],"years":[78,291,301,445],"and":[79,83,87,89,98,141,151,161,167,195,264,298,337,377,384,432],"\u2265":[80,299,342,414,443],"18":[81,290,300,444],"years)":[82],"primary":[84,272,451],"site":[85],"(pelvic":[86],"non-pelvic),":[88],"randomized":[90],"receive":[92],"14":[93],"cycles":[94],"alternating":[96],"vincristine-doxorubicin-cyclophosphamide":[97],"ifosfamide-etoposide":[99],"given":[100],"every":[101,108],"weeks":[103,110],"(ST;":[104],"Regimen":[105,112],"A)":[106],"vs.":[107,262,270,296,306,357,413],"(IC;":[111],"B).":[113],"For":[114],"this":[115,135],"updated":[116],"report,":[117],"one":[118],"patient":[119],"excluded":[121],"due":[122],"uncertainty":[124],"original":[126],"diagnosis":[127],"giving":[128],"a":[129,244],"total":[130],"567":[132],"analysis.":[136],"Data":[137],"for":[138,170,178,189,206,220,236,280,330,339,391,406,424,457,465],"tumor":[139,336,345,356,360,393],"measurements":[140],"histologic":[142,316],"response":[143,317],"collected":[145],"retrospectively":[146],"from":[147,322,379],"institutional":[148],"reports.":[149],"EFS":[150,177,249,277,321,376,405,431],"overall":[152],"(OS)":[154],"estimated":[156],"using":[157,163],"Kaplan-Meier":[159],"method":[160],"log-rank":[165],"test":[166,169],"Gray\u2019s":[168],"cumulative":[171],"incidence":[172],"(CI).":[173],"Results:":[174],"The":[175,212],"10-year":[176,213,248,276,320,375,404],"chemo":[183,191,202,208,222,238,254,285,373],"70%":[185],"61%":[188],"ST":[190,207,221],"(p":[192,209,239,346],"=":[193,210,240,259,267,293,303,347],"0.03),":[194],"OS":[197,378,433],"76%":[199,329],"69%":[205],"0.03).":[211],"CI":[214],"second":[216],"malignant":[217],"neoplasms":[218],"(SMNs)":[219],"4.2%":[224],"[95%":[225],"confidence":[226,233],"interval:":[227,234],"2.4-7.5]":[228],"3.2%":[231],"(95%":[232],"1.6-6.3)":[235],"0.5).":[241],"There":[242],"trend":[245],"towards":[246],"improved":[247],"those":[251,331,340],"both":[255,287],"non-pelvic":[257],"(N":[258,266,292,302],"477;":[260],"71%":[261],"64%)":[263,297],"pelvic":[265,450],"90;":[268],"67%":[269],"43%)":[271],"tumors.":[273],"Similarly,":[274],"<":[289,333,410],"500;":[294],"73%":[295],"67;":[304],"53%":[305],"37%)":[307],"groups.":[309],"Among":[310],"184":[312],"available":[315],"data,":[318],"time":[324],"local":[326,380],"control":[327,381],"10%":[334,343],"viable":[335,344,355,359],"56%":[338],"0.01).":[348],"Additional":[349],"analysis":[350],"comparing":[351],"any":[354],"no":[358,400],"(NVT)":[361],"treatment":[363,467],"regimen":[364],"that":[366],"NVT":[369],"who":[370],"received":[371],"had":[374],"91%":[383],"97%,":[385],"respectively.":[386],"In":[387],"210":[389],"whom":[392],"volume":[394],"calculations":[395],"possible,":[397],"there":[398],"difference":[401],"tumors":[409,452],"200":[411,415],"mL":[412],"mL.":[416],"Conclusions:":[417],"With":[418],"longer":[419],"term":[420],"follow-up,":[421],"ES":[426],"is":[427],"associated":[428],"without":[434],"an":[435],"increase":[436],"SMNs.":[438],"This":[439],"suggests":[441],"poor":[447],"necrosis":[448],"or":[449],"remain":[453],"high":[455],"risk":[456],"relapse":[458],"despite":[459],"chemo,":[461],"emphasizing":[462],"need":[464],"alternative":[466],"strategies":[468],"improve":[470],"their":[471],"outcomes.":[472],"Clinical":[473],"trial":[474],"information:":[475],"NCT00006734.":[476]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2022-06-13T00:00:00"}